Ayurcann Holdings Corp.
AYURF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.07 | -0.04 | -0.01 | 0.22 |
| FCF Yield | -4.90% | -7.35% | -2.53% | -15.06% |
| EV / EBITDA | -5.68 | -1.67 | -3.82 | 1.75 |
| Quality | ||||
| ROIC | -227.42% | -189.36% | -57.25% | -201.54% |
| Gross Margin | 33.65% | 29.46% | 23.66% | 60.61% |
| Cash Conversion Ratio | 0.02 | 0.05 | 0.02 | 0.71 |
| Growth | ||||
| Revenue 3-Year CAGR | 38.91% | 17.84% | – | – |
| Free Cash Flow Growth | 5.95% | -81.85% | 55.80% | -199.88% |
| Safety | ||||
| Net Debt / EBITDA | -0.25 | 0.19 | 0.34 | -0.10 |
| Interest Coverage | -4.54 | -177.01 | -36.56 | 6.85 |
| Efficiency | ||||
| Inventory Turnover | 3.11 | 2.69 | 2.43 | 1.30 |
| Cash Conversion Cycle | 102.44 | 192.15 | 163.65 | 259.78 |